Do Unresectable Giant Cell Tumors of Bone Treated With Denosumab Progress After Discontinuation of Treatment?

Do Unresectable Giant Cell Tumors of Bone Treated With Denosumab Progress After Discontinuation of Treatment?

ABSTRACT Background Denosumab represents a valuable treatment option for unresectable giant cell tumors of the bone (GCTBs). However, no standardized protocols exist determining the length of administration, with few studies having been published on patients who reached the end of treatment. Aims To...

Full description

Saved in:
Bibliographic Details
Main Authors: DENO Research Group, Carolina de laCalva, Manuel Angulo, Paula González‐Rojo, Ana Peiró, Pau Machado, Juan Luis Cebrián, Roberto García‐Maroto, Antonio Valcárcel, Pablo Puertas, Gregorio Valero‐Cifuentes, Óscar Pablos, Miriam Maireles, María Luisa Fontalva, Iván Chaves, Aida Orce, Luis Coll‐Mesa, Israel Pérez, Fausto González, María delCarmen Sanz, Isidro Gracia
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Cancer Reports
Subjects:
denosumab
giant cell tumors of bone
recurrence
unresectable
Online Access:https://doi.org/10.1002/cnr2.70117
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items